PMID: 370671Jun 1, 1978

Vertebrate GABA receptors

Neurochemical Research
F V DeFeudis


Physiologic-pharmacologic studies in vivo and with tissue cultures have revealed that synaptic GABA receptors exist in the vertebrate CNS. The GABA antagonist, bicuculline, can be used to detect synaptic GABA receptors in both the presence and absence of Na+, even though GABA binding to cerebral subcellular fractions occurs mainly to transport (uptake) receptors in the presence of Na+.


Jun 10, 1976·The New England Journal of Medicine·S J EnnaS H Snyder
Apr 1, 1976·The Journal of Pharmacy and Pharmacology·A Dray, D W Straughan
Jul 15, 1975·Life Sciences·E CostaA Suria
Nov 1, 1976·Brain Research Bulletin·E J PeckB R Lester
Apr 1, 1977·Journal of Neurochemistry·S J Enna, S H Snyder
Sep 1, 1977·Life Sciences·K G LloydE D Bird
Jan 1, 1977·Progress in Neurobiology·F V DeFeudis
Jan 1, 1975·Journal of Neurochemistry·G A JohnstonB Twitchin
Feb 1, 1977·The American Journal of Psychiatry·D P Van Kammen
Sep 1, 1977·Nature·S N Kozhechkin, R U Ostrovskay
Oct 8, 1976·Brain Research·S J Enna, S H Snyder
Dec 17, 1976·Brain Research·D R CurtisS J Brand
Jul 1, 1975·Journal of Neurochemistry·I A SytinskyN N Konovalova

Related Concepts

Gaba Receptor Activity
GABA Antagonists
Receptors, Drug
GABA Receptor
Subcellular Fractions
Cerebral Hemisphere Structure (Body Structure)

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.